Invesco Ltd. Theravance Biopharma, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 46,050 shares of TBPH stock, worth $430,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,050

Previous 44,474 3.54%

Holding current value

$430,567

Previous $358,000 20.95%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.93 - $10.08 $12,497 - $15,886	1,576 Added 3.54%	46,050 $433,000
Q3 2024 Nov 12, 2024	BUY	$7.66 - $10.25 $2,688 - $3,597	351 Added 0.8%	44,474 $358,000
Q2 2024 Aug 13, 2024	SELL	$8.29 - $9.92 $677,939 - $811,237	-81,778 Reduced 64.95%	44,123 $374,000
Q1 2024 May 14, 2024	BUY	$8.22 - $11.59 $503,187 - $709,481	61,215 Added 94.63%	125,901 $1.13 Million
Q4 2023 Feb 12, 2024	SELL	$8.58 - $11.4 $340,583 - $452,523	-39,695 Reduced 38.03%	64,686 $727,000
Q3 2023 Nov 13, 2023	BUY	$8.38 - $10.44 $431,821 - $537,973	51,530 Added 97.5%	104,381 $900,000
Q2 2023 Aug 11, 2023	BUY	$10.16 - $11.92 $3,545 - $4,160	349 Added 0.66%	52,851 $547,000
Q1 2023 May 12, 2023	BUY	$9.87 - $11.44 $235,892 - $273,416	23,900 Added 83.56%	52,502 $569,000
Q4 2022 Feb 13, 2023	SELL	$9.65 - $11.34 $4,786 - $5,624	-496 Reduced 1.7%	28,602 $320,000
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $23,634 - $28,789	2,817 Added 10.72%	29,098 $296,000
Q2 2022 Aug 15, 2022	BUY	$8.41 - $10.34 $3,136 - $3,856	373 Added 1.44%	26,281 $238,000
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $1,491 - $2,319	179 Added 0.7%	25,908 $248,000
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $11,300 - $16,829	-1,523 Reduced 5.59%	25,729 $284,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $36,828 - $78,390	5,440 Added 24.94%	27,252 $202,000
Q2 2021 Aug 17, 2021	BUY	$14.52 - $22.46 $138,056 - $213,549	9,508 Added 77.28%	21,812 $317,000
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $37,630 - $47,872	2,271 Added 22.64%	12,304 $251,000
Q4 2020 Feb 16, 2021	BUY	$14.89 - $20.16 $149,391 - $202,265	10,033 New	10,033 $179,000
Q2 2020 Aug 14, 2020	SELL	$20.64 - $30.69 $524,421 - $779,771	-25,408 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $453,278 - $792,983	25,408 New	25,408 $587,000
Q2 2019 Aug 14, 2019	SELL	$15.6 - $25.15 $205,764 - $331,728	-13,190 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$22.57 - $28.15 $266,055 - $331,832	-11,788 Reduced 47.19%	13,190 $299,000
Q4 2018 Feb 14, 2019	BUY	$22.52 - $35.07 $562,504 - $875,978	24,978 New	24,978 $639,000

Others Institutions Holding TBPH

# of Institutions

129

Shares Held

46.5M

Call Options Held

600

Put Options Held

300

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $624M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account